IL95663A0 - Stabilized aqueous formulations of small peptides - Google Patents

Stabilized aqueous formulations of small peptides

Info

Publication number
IL95663A0
IL95663A0 IL95663A IL9566390A IL95663A0 IL 95663 A0 IL95663 A0 IL 95663A0 IL 95663 A IL95663 A IL 95663A IL 9566390 A IL9566390 A IL 9566390A IL 95663 A0 IL95663 A0 IL 95663A0
Authority
IL
Israel
Prior art keywords
small peptides
aqueous formulations
stabilized aqueous
stabilized
formulations
Prior art date
Application number
IL95663A
Other languages
English (en)
Original Assignee
Immunobiology Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Res Inst Inc filed Critical Immunobiology Res Inst Inc
Publication of IL95663A0 publication Critical patent/IL95663A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL95663A 1989-09-28 1990-09-12 Stabilized aqueous formulations of small peptides IL95663A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41384189A 1989-09-28 1989-09-28

Publications (1)

Publication Number Publication Date
IL95663A0 true IL95663A0 (en) 1991-06-30

Family

ID=23638883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95663A IL95663A0 (en) 1989-09-28 1990-09-12 Stabilized aqueous formulations of small peptides

Country Status (14)

Country Link
EP (1) EP0420649A3 (ja)
JP (1) JPH04502017A (ja)
AU (1) AU6446790A (ja)
BR (1) BR9006934A (ja)
CA (1) CA2026149A1 (ja)
DD (1) DD298053A5 (ja)
HU (1) HUT59013A (ja)
IE (1) IE903475A1 (ja)
IL (1) IL95663A0 (ja)
IT (1) IT1240314B (ja)
NZ (1) NZ235324A (ja)
PT (1) PT95451A (ja)
WO (1) WO1991004743A1 (ja)
ZA (1) ZA907492B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
JP5485489B2 (ja) * 2000-08-11 2014-05-07 中外製薬株式会社 抗体含有安定化製剤
US7425618B2 (en) 2002-06-14 2008-09-16 Medimmune, Inc. Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2107069B1 (en) 2003-08-05 2013-01-16 Novo Nordisk A/S Novel insulin derivatives
DE202004020676U1 (de) 2004-03-10 2005-11-10 Bioceuticals Arzneimittel Ag Erythropoietin-Flüssigformulierung
US20090074882A1 (en) 2005-12-28 2009-03-19 Novo Nordisk A/S Insulin compositions and method of making a composition
JP5552046B2 (ja) 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー／エス インスリン誘導体を含有する薬学的製剤
US20120213846A1 (en) 2008-08-15 2012-08-23 Forest Laboratories Holdings Limited Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
KR20110085985A (ko) 2008-10-30 2011-07-27 노보 노르디스크 에이/에스 하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
US8329649B2 (en) 2008-11-04 2012-12-11 Aska Pharmaceutical Co., Ltd. Aqueous composition containing follicle-stimulating hormone and histidine
US8748573B2 (en) 2009-08-06 2014-06-10 Ironwood Pharmaceuticals, Inc. Formulations comprising linaclotide
AR080428A1 (es) 2010-01-20 2012-04-11 Chugai Pharmaceutical Co Ltd Formulaciones liquidas estabilizadas contentivas de anticuerpos
WO2011103311A2 (en) 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
HRP20192207T1 (hr) 2010-08-11 2020-02-21 Ironwood Pharmaceuticals, Inc. Stabilne formulacije linaklotida
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
WO2012143418A1 (en) 2011-04-20 2012-10-26 Sandoz Ag STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc
HUE032237T2 (en) 2011-08-17 2017-09-28 Ironwood Pharmaceuticals Inc Treatments for gastrointestinal disorders
SG11201401562RA (en) 2011-10-18 2014-09-26 Coherus Biosciences Inc Etanercept formulations stabilized with sodium chloride
US10493151B2 (en) 2011-10-18 2019-12-03 Coherus Biosciences, Inc. Etanercept formulations stabilized with sodium chloride
AU2013315750B9 (en) 2012-09-11 2018-11-15 Coherus Biosciences, Inc. Correctly folded etanercept in high purity and excellent yield
JP2016519127A (ja) 2013-04-30 2016-06-30 ノヴォ ノルディスク アー／エス 新規投与レジメン
CN105012232B (zh) * 2015-08-14 2017-09-05 北京世桥生物制药有限公司 一种胸腺五肽注射液及其制作方法
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2020128499A1 (en) * 2018-12-21 2020-06-25 Arecor Limited Novel composition
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
TWI872251B (zh) 2020-05-29 2025-02-11 日商中外製藥股份有限公司 含有抗體製劑
US20240366731A1 (en) 2021-08-12 2024-11-07 Celagenex Research (India) Pvt. Ltd. Oral algal oil based gastro-intestinal tract permeable peptide composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
JPS57169425A (en) * 1981-04-10 1982-10-19 Eisai Co Ltd Composition and method for preventing adsorption of secretin
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4749690A (en) * 1986-01-27 1988-06-07 Ortho Pharmaceutical Corporation Treatment of allergy with thymopentin
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator

Also Published As

Publication number Publication date
WO1991004743A1 (en) 1991-04-18
IT9019421A1 (it) 1991-03-29
NZ235324A (en) 1992-07-28
AU6446790A (en) 1991-04-28
EP0420649A2 (en) 1991-04-03
EP0420649A3 (en) 1991-07-31
JPH04502017A (ja) 1992-04-09
HU907939D0 (en) 1991-08-28
IE903475A1 (en) 1991-04-10
BR9006934A (pt) 1991-10-22
PT95451A (pt) 1991-05-22
IT9019421A0 (it) 1990-02-20
ZA907492B (en) 1991-10-30
DD298053A5 (de) 1992-02-06
IT1240314B (it) 1993-12-07
HUT59013A (en) 1992-04-28
CA2026149A1 (en) 1991-03-29

Similar Documents

Publication Publication Date Title
EP0420649A3 (en) Stabilized aqueous formulations of small peptides
HUP0000589A3 (en) Aqueous formulations of peptides
HU9201966D0 (en) An improved vaccine of meningococcus-polysaccharide conjunction
EP0390930A4 (en) Stable aqueous preparation of active vitamin d 3?
GB8908250D0 (en) Formulations
IL96306A0 (en) Preparation of deoxyfluoronucleosides
SG47072A1 (en) Water-containing external preparations
ZA902519B (en) Pharmaceutical formulations
AP9000174A0 (en) Antiparasitical formulations
EP0450100A4 (en) Physiologically active peptide
GB8619182D0 (en) Peptides & derivatives
GB8916391D0 (en) Preparation of polyacetals
FI912461A7 (fi) Pienten peptidien stabiloituja vesipitoisia formuloita
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
GB8918394D0 (en) Preparation of polyhemiacetals
IL89362A0 (en) Preparation of tetrabromotetralin
CS275222B2 (en) Analogues of deamino-vasopressin
GB8808440D0 (en) Preparation of peptide derivatives
IE893752L (en) Preparation of n-acyl-aminomethyl-phosphonates
IE892415L (en) Preparation of polyhydroxysilazanes
IE894144L (en) Preparation of deglucoteicoplanin
IE892537L (en) Preparation of trifluoroethanol.
IE890708L (en) Peptide equivalents of non-peptides
GB8619181D0 (en) Peptides & derivatives
GB8828413D0 (en) Ws7528 substance & preparation thereof